This kitchen robot will cook dinner for you, but you still have to do the prep. The POA is an induction cooktop with a robotic arm that takes ingredients that you've prepped and put into these four containers based on a pre-programmed guided cooking recipe using a camera with AI powered features. Of course, it monitors the cooking to in theory make sure that your dish comes out perfect.It also adds spices and herbs at the appropriate time during the cook. Plus features water and oil dispensers so that reall ...

Clinical Trial Progress & Results - Neuralink successfully completed its first human trial surgery in the UK, with the participant, Paul, paralyzed due to motor neuron disease (likely ALS), able to control a computer with his thoughts hours after surgery [1][3][4] - Neuralink's total patient count is now 13 across four hospital sites: Phoenix, Miami, Toronto, and London [6] - Neuralink's eighth patient, Nick Ray, demonstrated the ability to control an assisted robotic arm via Bluetooth, showcasing both digital and physical freedom [1][6][9] - Science, a competitor led by Max Hodak, reported that over 80% (26 out of 32) of their study participants experienced meaningful improvement in vision after one year using their 2mm x 2mm retinal implant [2][15][17] Technological Advancements & Applications - Neuralink's device allows patients to control computers and robotic arms with their minds, offering potential for restoring autonomy and enriching daily life [4][5][9] - Neuralink is working towards enabling 22 degrees of freedom of control with Tesla's Optimus robot, expanding beyond the current 7 degrees of freedom with the robotic arm [12] - Neuralink is developing a speech restoration clinical trial study at Cleveland Clinic Abu Dhabi [25] Business Expansion & Strategy - Neuralink has leased a 144,000 sq ft property in South San Francisco, expanding its presence in Silicon Valley in addition to its ongoing expansion in Austin, Texas [2][12] Future Outlook & Developments - Neuralink is expected to begin trials for blindsight next year [18] - Neuralink submitted a paper to the New England Journal of Medicine describing the first three patients implanted with the Neuralink device, including safety data [25]

Medical Technology Advancement - Neuralink's BCI device enables ALS patient to control a robotic arm [1] - The BCI technology allows the patient to regain the ability to feed himself [1] - The patient expresses satisfaction and optimism about future advancements of the BCI [1] Company Impact - Neuralink team receives recognition for their work [1]

Company Development - Neuralink allowed a paralyzed ALS patient to control a robotic arm using his thoughts [1] - The patient was able to feed himself using the robotic arm [1]

Summary of Key Points from the Research Report Industry Overview - The report focuses on the **humanoid robot industry** and its developments showcased at the **China Industrial Industry Fair (CIIF)** held in Shanghai on **24 September 2025** [3][4]. Core Insights - **Hardware vs. Software**: Hardware is not seen as a bottleneck for humanoid robots, with significant cost reductions in components. The price for dexterous hands has decreased from **RMB50-100k** to **RMB10-60k** per hand, with Linkerbot's offering at **RMB8.8k** per hand [3]. However, software remains underdeveloped, with key AI models still in training [3]. - **Cost Reduction**: Overseas companies like Nidec are relocating supply chains to China, which is expected to further reduce costs in components as mass production of humanoid robots begins [3]. - **Software Development**: Unitree's recent open-sourcing of its world model aims to enhance the software ecosystem for humanoid robots, particularly benefiting educational institutions [3]. Company Highlights - **Inovance**: Unveiled new humanoid robot products, including a robotic arm and various actuators. The company plans to start commercial production in **2026**, with an estimated actuator value of **RMB34k/unit** by **2030**. The global humanoid robot market is projected to reach **1.1 million shipments** by **2030**, indicating a market size of approximately **RMB37 billion** [4]. - **Preferred Picks**: Inovance, Hongfa, and Shuanghuan are highlighted as preferred investment choices due to their strong market positions and growth potential [5][9]. Stock Ratings and Valuations - **Inovance (300124 CH)**: Current price **RMB86.33**, target price **RMB96.00**, with an upside of **11.2%**. The company is expected to benefit from a recovery in factory automation [6][10]. - **Hongfa (600885 CH)**: Current price **RMB25.74**, target price **RMB39.10**, with an upside of **51.9%**. Strong earnings momentum is anticipated due to new car model launches [6][10]. - **Shuanghuan (002472 CH)**: Current price **RMB51.31**, target price **RMB58.00**, with an upside of **13.0%**. Growth in smart drive units and robotic reducers is expected to drive future performance [6][10]. Risks and Considerations - **Inovance Risks**: Weaker-than-expected demand in automation and intense competition could impact margins [10]. - **Hongfa Risks**: Potential risks include slower-than-expected relay demand and cost declines [10]. - **Shuanghuan Risks**: Risks include slower commercialization of humanoid robots and lower-than-expected market share gains [10]. Additional Insights - The report emphasizes the importance of software development in the humanoid robot sector, indicating that while hardware costs are decreasing, the maturity of software solutions is critical for future growth [3][9]. - The anticipated growth in the humanoid robot market presents significant investment opportunities, particularly for companies that can innovate in both hardware and software [4][5].

Technological Advancement - Neuralink trial participant can control a robotic arm with their mind [1] - The technology enables writing and drawing via robotic arm control [1]